All four isomeric series of novel 4-substituted pyrido-fused 7-deazapurine ribonucleosides possessing the pyridine nitrogen atom at different positions were designed and synthesized. The total synthesis of each isomeric fused heterocycle through multistep heterocyclization was followed by glycosylation and derivatization at position 4 by cross-coupling reactions or nucleophilic substitutions.
All compounds were tested for cytostatic and antiviral activity. The most active were pyrido[4 ',3 ':4,5]pyrimidine nucleosides bearing MeO, NH2, MeS, or CH(3)groups at position 4, which showed submicromolar cytotoxic effects and good selectivity for cancer cells.
The mechanism involved activation by phosphorylation and incorporation to DNA where the presence of the modified ribonucleosides causes double-strand breaks and apoptosis.